New Strategies for Laboratory Testing of von Willebrand Factor

SelectScience Webinar

There have been recent advances in von Willebrand disease (vWD) testing as well as recent updates in the diagnosis and management of vWD.  Paradigm shifts in vWD testing in the context of new guidelines will likely lead to improvements in vWD diagnosis.  This educational session will highlight these current diagnostic approaches and the advantages of new testing strategies.

Dr. Wong currently provides medical oversight in the hematology department at Quest Diagnostics, Nichols Institute at Chantilly, VA. He was previously the medical director for hematology and associate medical director in transfusion medicine at Children’s National Hospital in Washington, DC. Dr. Wong received his medical degree from Washington University and completed a clinical pathology residency at Barnes-Jewish Hospital in St. Louis, MO will transfusion medicine fellowship training at UNC Chapel Hill, and in the Department of Transfusion Medicine, at the National Institutes of Health. He has been involved and continues to be involved in the training of pathology residents in the Washington DC area and has current research interests in heparin induced thrombocytopenia, von Willebrand disease testing, therapeutic apheresis outcomes, and pediatric reference intervals.

• Understand what is current biological function of von Willebrand factor and how that understanding affects testing strategies in the diagnosis of vWD
• Understand potentially new testing strategies in the diagnosis of vWD
• Understand what are the new changes in the ASH ISTH NHF WFH 2021 guidelines on the diagnosis of vWD

Relevant to clinicians (especially adult and pediatric hematologists), healthcare professionals, laboratorians, and specialists